Skip to main content

Nayzilam News

Study Looks at Links Between Anxiety Disorders, Benzodiazepines, Dementia

MONDAY, Aug. 14, 2023 – Benzodiazepines and anxiety disorders are associated with dementia risk, but for patients with anxiety disorders, no additional risk is seen with benzodiazepine use,...

Variation Seen in Dosing of Meds at Prehospital Pediatric Encounters

MONDAY, July 10, 2023 – For pediatric patients in the prehospital setting, weight-based dosing often varies from national guidelines, according to a study published online July 10 in Pediatrics....

FDA Medwatch Alert: Drug Safety Communication: Benzodiazepine Drug Class - Boxed Warning Updated to Improve Safe Use

ISSUE: The FDA is requiring the Boxed Warning, FDA’s most prominent warning, be updated by adding other information to the prescribing information for all benzodiazepine medicines. This information w...

FDA Approves Nayzilam (midazolam) Nasal Spray to Treat Seizure Clusters

Brussels (Belgium) & Atlanta, Georgia (U.S.) – May 20 2019: UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application for the company’s newest ant...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Seizures

Nayzilam patient information at Drugs.com